| Logo | Name | Σ |
|---|---|---|
 | Dia & Co The Challenge: 67% of American women wear sizes 14+—that’s 100 million women. Yet this majority is systematically underserved by the retail industry. The plus size community faces paltry options, unwelcoming environments, and a lack of representation—all adding up to a disappointing experience with style. Our Vision: Style freedom through a life well-lived The Dia & Co Solution: Dia & Co is the only retail service dedicated to meeting the plus size community’s full range of style needs. We’re applying the best of data and technology to serve women who have been ignored for far too long—from developing the shopping experiences … Sectors: Semiconductors | 2600 |
 | Greater Paris University Hospitals - AP-HP Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par … Sectors: Health | 2261 |
 | numeum Numeum is the employers' union and the 1st organization of digital professionals in France. Numeum is the 1st professional organization of digital technology in France. Member of the Syntec Federation which is the second representative branch of MEDEF, we bring together more than 2,500 members of the members of members: digital service companies (ESN), software publishers, platforms and engineering and technology consulting companies (ICT). All of these companies generate 85 % of total turnover in the sector. Our actions: - Value our members, our professions and defend their interests - embody digital France in Europe - Animate the digital ecosystem … | 1337 |
 | Inria The French national research institute for digital science and technology World-leading research and technological innovation are an integral part of its DNA. Inria's 3,500 researchers and engineers put their passion for digital technology to work in nearly 200 project teams, most of which are joint teams with our academic partners, including major research universities and the CNRS. They explore new fields, often in collaboration with different disciplines and industrial partners, with the aim of meeting ambitious challenges. As a technology institute, Inria supports the development of numerous software products, sometimes making a global impact via the opensource model. Because technology … Sectors: Research | 2178 |
 | Leem The professional organization of drug companies operating in France. Leem, medication companies, brings together companies in the pharmaceutical industry in France. Created over 130 years ago, the Leem now has nearly 270 adhering companies, which have almost 98 % of the total medication turnover in France. The pharmaceutical industry employs 100,000 people in more than 150 trades, and has recruited 10,000 employees per year for 10 years. Each year, the pharmaceutical industry invests 12 % of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its R & AMP; D … Sectors: Startup accelerator & VC | 755 |
 | CNIL - Commission Nationale de l'Informatique et des Libertés French Data Protection Authority In the digital world, the National Commission for Data Protection (CNIL) is the regulator of personal data. Created in 1978 by the Data Protection Act, the CNIL is an independent administrative authority that supports professionals in their compliance and helps individuals to control their personal data and exercise their rights. It analyzes the impact of technological innovations and emerging uses on privacy and freedoms. Finally, she works in close collaboration with her European and international counterparts to develop harmonized regulation. To know its missions in more detail 👉 https://www.cnil.fr/fr/les-mission Find out more about the management of … | 777 |
 | Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we … Sectors: Biotechnology | 717 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: Biotechnology Startup accelerator & VC | 938 |
 | Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: Pharmaceutical | 4634 |
 | EY EY is building a better working world by creating new value for clients, people, society, the planet, while building trust in the capital markets. Enabled by data, AI and advanced technology, EY teams help clients shape the future with confidence and develop answers for the most pressing issues of today and tomorrow. EY teams in more than 150 countries work across a full spectrum of services in assurance, consulting, tax, strategy and transactions, strengthened by sector experience and diverse ecosystem partners. Find out more about the EY global network: http://ey.com/en_gl/legal-statement Advisory, Assurance, Tax, Transactions, Audit, Mergers, M&A, Financial Services, Accounting, … Sectors: Consulting, audit | 5934 |
 | Boehringer Ingelheim Our people are our strength. And, together with over 54,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice Imprint: https://www.boehringer-ingelheim.com/imprint Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: Animal Health Pharmaceutical | 1964 |
 | Agence du numérique en santé The Digital Health Agency The agency of shared health information systems is a state agency under the supervision of the Ministry of Social Affairs and Health, which aims to promote the development of information systems in the health field and the medico-social sector. ASIP Health aims to contribute to improving coordination and quality of care. A benchmark and unifying player in e-health, its missions extend from the design and deployment of health information systems, such as the personal medical file (DMP) or telemedicine projects, project management and the management of the healthcare professional (CPS). ASIP Health is also responsible for … | 426 |
 | ANSM Agence nationale de sécurité du médicament et des produits de santé For safe, efficient, innovative and accessible health products The National Agency for the Safety of Medicines and Health Products is the public player who allows, on behalf of the State, access to health products in France and which ensures their safety throughout their life cycle. At the heart of the health system, we act at the service of patients and their safety. We promote access to innovative products via authorization procedures adapted to each stage of the life of the drug before and after its placing on the market. Through our assessments, expertise and our surveillance policy, we make sure … | 188 |
 | Haute Autorité de Santé Official page of the High Authority for Health (HAS), independent public authority of a scientific nature HAS is an independent public authority which aims to contribute to the regulation of the health system by quality. Its missions in the fields of the evaluation of health products, professional practices, organization of care and public health, aim to provide all patients and users with sustainable and equitable access to as effective, safe and efficient care as possible. | 556 |
 | Agence Régionale de Santé Grand Est Act for the health of all The Regional Health Agency is the interlocutor of health professionals and the medico -social sector, state services, local authorities, elected officials, managers, users and their representatives. It dialogue with all the territories and its actions are carried out while respecting the rights of users and in consultation with the bodies of health democracy. care offer, medico-social offer, public health, and health democracy | 222 |
 | Ministère de la Santé Official account of the ministry responsible for health and access to care. The Ministry of Health and Access to Care prepares and implements government policy in the fields of public health, prevention and access to care. health, solidarity, public administration, poverty, care, and solidarity | 1478 |
 | Institut Curie Together, let's take speed cancer A recognized foundation of public utility, the Curie Institute associates one of the largest European research centers in cancerology and two cutting -edge hospitals. Founded in 1909 on a model designed by Marie Curie and still avant-garde, "from basic research to innovative care", the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administratives. Care The hospital ensemble of the Curie Institute is a reference center for breast cancers, eye tumors and pediatric cancers in particular. Research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bio-informatians and doctors are mobilizing, … Sectors: Health | 988 |
 | Takeda Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our … Sectors: Pharmaceutical | 1040 |
 | Eurostat High quality statistics and data on Europe. Lawful good. EUROSTAT is the statistical office of the European Union. Our mission is to provide high quality statistics and data on Europe. Our values: Show respect for our staff, partners and users Strive for excellence in everything we do Drive innovation in official statistics Promote service orientation Uphold professional independence ESS partnership Eurostat produces European statistics in partnership with National Statistical Institutes and other national authorities in the EU Member States. This partnership is known as the European Statistical System (ESS). It also includes the statistical authorities of the European Economic Area … Sectors: European Union | 11001 |
 | Bpifrance Bpifrance account, the public investment bank. Bpifrance, public investment bank, supports businesses, from priming to stock market quotes, from credit to equity. A privileged interlocutor, Bpifrance offers in each region financing or investment solutions adapted to each stage of business life. Bank partner of entrepreneurs, Bpifrance supports them sustainably to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing of SMEs, business creation, international development, investment, creation/transmission, innovation, support, acceleration, and export guarantee Sectors: Bank | 13084 |
 | Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: Biotechnology Pharmaceutical | 1672 |
 | Novartis Reimagining medicine, together Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: Pharmaceutical | 1856 |
 | Illumina Unlocking the Power of the Genome At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of … Sectors: Biotechnology | 229 |
 | Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: Biotechnology | 1653 |
 | Alexion Pharmaceuticals, Inc. Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex … Sectors: Biotechnology Pharmaceutical | 274 |
 | Vertex Pharmaceuticals Sectors: Biotechnology | 651 |